BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8019455)

  • 1. Cytokine involvement in predicting clinical graft-versus-host disease in allogeneic bone marrow transplant recipients.
    Dickinson AM; Sviland L; Hamilton PJ; Usher P; Taylor P; Jackson G; Dunn J; Proctor SJ
    Bone Marrow Transplant; 1994 Jan; 13(1):65-70. PubMed ID: 8019455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of direct involvement of cytokines in graft-versus-host reactions using an in vitro human skin explant model.
    Dickinson AM; Sviland L; Dunn J; Carey P; Proctor SJ
    Bone Marrow Transplant; 1991 Mar; 7(3):209-16. PubMed ID: 1829387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vitro predictive test for clinical graft-versus-host disease in allogeneic bone marrow transplant recipients.
    Sviland L; Dickinson AM; Carey PJ; Pearson AD; Proctor SJ
    Bone Marrow Transplant; 1990 Feb; 5(2):105-9. PubMed ID: 1968774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.
    Imamura M; Hashino S; Kobayashi H; Kubayashi S; Hirano S; Minagawa T; Tanaka J; Fujii Y; Kobayashi M; Kasai M
    Bone Marrow Transplant; 1994 Jun; 13(6):745-51. PubMed ID: 7920309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin explant model of human graft-versus-host disease: prediction of clinical outcome and correlation with biological risk factors.
    Wang XN; Collin M; Sviland L; Marshall S; Jackson G; Schulz U; Holler E; Karrer S; Greinix H; Elahi F; Hromadnikova I; Dickinson AM
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):152-9. PubMed ID: 16443513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of MHC class I and II antigens by keratinocytes and enterocytes in acute graft-versus-host disease. Newcastle Bone Marrow Transplant Group.
    Sviland L; Pearson AD; Green MA; Eastham EJ; Malcolm AJ; Proctor SJ; Hamilton PJ
    Bone Marrow Transplant; 1989 May; 4(3):233-8. PubMed ID: 2659108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for acute graft-versus-host disease in 291 consecutive HLA-identical bone marrow transplant recipients.
    Hägglund H; Boström L; Remberger M; Ljungman P; Nilsson B; Ringdén O
    Bone Marrow Transplant; 1995 Dec; 16(6):747-53. PubMed ID: 8750264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A method for modeling skin explants--an in vitro predictive test for graft vs host disease in allogenic hematopoietic cell transplantation].
    Hromadníková I; Sedlácek P; Starý J; Vavrinec J; Cermáková-Frantlová M; Stechová K; Houbová B; Vítek A; Sajdová J; Sviland L; Dickinson AM
    Cas Lek Cesk; 2001 Feb; 140(3):73-8. PubMed ID: 11284422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic reaction induces dendritic cell maturation through proinflammatory cytokine secretion.
    Laurin D; Kanitakis J; Bienvenu J; Bardin C; Bernaud J; Lebecque S; Gebuhrer L; Rigal D; Eljaafari A
    Transplantation; 2004 Jan; 77(2):267-75. PubMed ID: 14742992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a skin explant model for predicting GVHD in HLA-matched bone marrow transplants - effect of GVHD prophylaxis.
    Dickinson A; Hromadníková I; Sviland L; Jackson G; Taylor P; Vavrinec J; Sedlácek P; Cermáková M; Starý J; Vítek A; Sajdová J; Proctor S
    Bone Marrow Transplant; 1999 Oct; 24(8):857-63. PubMed ID: 10516697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
    Leung AY; Kwok J; Lie AK; Chen P; Chen FE; Liang R
    Haematologica; 2001 Jun; 86(6):652-6. PubMed ID: 11418376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets.
    Gaschet J; Gallot G; Ibisch C; Lim A; Even J; Vivien R; Hallet MM; Milpied N; Vié H
    Bone Marrow Transplant; 1998 Aug; 22(4):385-92. PubMed ID: 9722075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of helper T lymphocyte precursor frequencies for graft-versus-host disease and graft-versus-leukaemia effects in allogeneic bone marrow transplantation.
    Russell CA; Heilmann C; Madsen HO; Vindeløv LL
    Bone Marrow Transplant; 2001 May; 27(9):949-58. PubMed ID: 11436105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary human keratinocytes as targets in predicting acute graft-versus-host disease following HLA-identical bone marrow transplantation.
    van Dijk AM; Kessler FL; Verdonck LF; Stadhouders-Keet SA; van Lier RA; de Gast GC; Otten HG
    Br J Haematol; 2000 Dec; 111(3):791-6. PubMed ID: 11122139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma-based mixed lymphocyte culture as a selection tool for allogeneic bone marrow donors other than identical siblings.
    van der Meer A; Wissink WM; Schattenberg AV; Joosten I
    Br J Haematol; 1999 May; 105(2):340-8. PubMed ID: 10233402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of recipient-specific alloreactivity: is GVHD predictable?
    Theobald M; Bunjes D; Nierle T; Arnold R; Heimpel H
    Bone Marrow Transplant; 1993; 12 Suppl 3():S18-23. PubMed ID: 8124251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human skin explant model for predicting graft-versus-host disease following bone marrow transplantation.
    Sviland L; Dickinson AM
    J Clin Pathol; 1999 Dec; 52(12):910-3. PubMed ID: 10711254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.